ID   MGAL_HUMAN              Reviewed;        2515 AA.
AC   Q2M2H8; A4D2I3; C9JNC2;
DT   10-JUN-2008, integrated into UniProtKB/Swiss-Prot.
DT   03-SEP-2014, sequence version 3.
DT   03-AUG-2022, entry version 126.
DE   RecName: Full=Probable maltase-glucoamylase 2 {ECO:0000305};
DE   AltName: Full=Maltase-glucoamylase (alpha-glucosidase) pseudogene;
DE   Includes:
DE     RecName: Full=Glucoamylase;
DE              EC=3.2.1.3;
DE     AltName: Full=Glucan 1,4-alpha-glucosidase;
GN   Name=MGAM2 {ECO:0000312|HGNC:HGNC:28101};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S., Kwasnicka D.,
RA   Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z., Lu F., Zeesman S.,
RA   Nowaczyk M.J., Teshima I., Chitayat D., Shuman C., Weksberg R.,
RA   Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J., Rahman N.,
RA   Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F., Belloni E.,
RA   Shaffer L.G., Pober B., Morton C.C., Gusella J.F., Bruns G.A.P., Korf B.R.,
RA   Quade B.J., Ligon A.H., Ferguson H., Higgins A.W., Leach N.T.,
RA   Herrick S.R., Lemyre E., Farra C.G., Kim H.-G., Summers A.M., Gripp K.W.,
RA   Roberts W., Szatmari P., Winsor E.J.T., Grzeschik K.-H., Teebi A.,
RA   Minassian B.A., Kere J., Armengol L., Pujana M.A., Estivill X.,
RA   Wilson M.D., Koop B.F., Tosi S., Moore G.E., Boright A.P., Zlotorynski E.,
RA   Kerem B., Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W., Mural R.J.,
RA   Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Hydrolysis of terminal (1->4)-linked alpha-D-glucose residues
CC         successively from non-reducing ends of the chains with release of
CC         beta-D-glucose.; EC=3.2.1.3;
CC   -!- INTERACTION:
CC       Q2M2H8; Q93009: USP7; NbExp=2; IntAct=EBI-20850333, EBI-302474;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass membrane
CC       protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q2M2H8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q2M2H8-3; Sequence=VSP_055415, VSP_055416;
CC   -!- SIMILARITY: Belongs to the glycosyl hydrolase 31 family. {ECO:0000305}.
CC   -!- CAUTION: Although it belongs to the glycosyl hydrolase 31 family, it
CC       lacks one active site residue, thus suggesting it may lack some enzyme
CC       activity. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC091742; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH236959; EAL23771.1; -; Genomic_DNA.
DR   EMBL; CH471198; EAW51984.1; -; Genomic_DNA.
DR   EMBL; BC111973; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC111975; -; NOT_ANNOTATED_CDS; mRNA.
DR   RefSeq; NP_001280555.1; NM_001293626.1. [Q2M2H8-1]
DR   AlphaFoldDB; Q2M2H8; -.
DR   SMR; Q2M2H8; -.
DR   BioGRID; 125025; 3.
DR   IntAct; Q2M2H8; 3.
DR   STRING; 9606.ENSP00000447431; -.
DR   BindingDB; Q2M2H8; -.
DR   ChEMBL; CHEMBL3833502; -.
DR   CAZy; GH31; Glycoside Hydrolase Family 31.
DR   GlyGen; Q2M2H8; 4 sites.
DR   iPTMnet; Q2M2H8; -.
DR   PhosphoSitePlus; Q2M2H8; -.
DR   BioMuta; MGAM2; -.
DR   DMDM; 190359876; -.
DR   EPD; Q2M2H8; -.
DR   jPOST; Q2M2H8; -.
DR   MassIVE; Q2M2H8; -.
DR   PeptideAtlas; Q2M2H8; -.
DR   PRIDE; Q2M2H8; -.
DR   Antibodypedia; 70894; 4 antibodies from 4 providers.
DR   DNASU; 93432; -.
DR   Ensembl; ENST00000477922.4; ENSP00000420449.3; ENSG00000257743.9. [Q2M2H8-1]
DR   Ensembl; ENST00000550469.6; ENSP00000447431.2; ENSG00000257743.9. [Q2M2H8-3]
DR   Ensembl; ENST00000622623.2; ENSP00000484330.1; ENSG00000278563.2. [Q2M2H8-3]
DR   Ensembl; ENST00000632823.1; ENSP00000488423.1; ENSG00000278563.2. [Q2M2H8-1]
DR   GeneID; 93432; -.
DR   KEGG; hsa:93432; -.
DR   MANE-Select; ENST00000477922.4; ENSP00000420449.3; NM_001293626.2; NP_001280555.1.
DR   UCSC; uc064isf.1; human. [Q2M2H8-1]
DR   CTD; 93432; -.
DR   DisGeNET; 93432; -.
DR   GeneCards; MGAM2; -.
DR   HGNC; HGNC:28101; MGAM2.
DR   HPA; ENSG00000257743; Group enriched (intestine, pancreas, salivary gland).
DR   neXtProt; NX_Q2M2H8; -.
DR   OpenTargets; ENSG00000257743; -.
DR   VEuPathDB; HostDB:ENSG00000257743; -.
DR   eggNOG; KOG1065; Eukaryota.
DR   GeneTree; ENSGT00940000163091; -.
DR   HOGENOM; CLU_000631_3_0_1; -.
DR   OMA; GVNSTYV; -.
DR   OrthoDB; 151244at2759; -.
DR   PhylomeDB; Q2M2H8; -.
DR   PathwayCommons; Q2M2H8; -.
DR   SignaLink; Q2M2H8; -.
DR   BioGRID-ORCS; 93432; 1 hit in 81 CRISPR screens.
DR   ChiTaRS; MGAM2; human.
DR   GenomeRNAi; 93432; -.
DR   Pharos; Q2M2H8; Tdark.
DR   PRO; PR:Q2M2H8; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; Q2M2H8; protein.
DR   Bgee; ENSG00000257743; Expressed in duodenum and 46 other tissues.
DR   Genevisible; Q2M2H8; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0004558; F:alpha-1,4-glucosidase activity; IBA:GO_Central.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:InterPro.
DR   GO; GO:0004339; F:glucan 1,4-alpha-glucosidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004553; F:hydrolase activity, hydrolyzing O-glycosyl compounds; IBA:GO_Central.
DR   GO; GO:0005975; P:carbohydrate metabolic process; IEA:InterPro.
DR   CDD; cd00111; Trefoil; 2.
DR   Gene3D; 2.60.40.1180; -; 4.
DR   Gene3D; 4.10.110.10; -; 2.
DR   InterPro; IPR031727; Gal_mutarotase_N.
DR   InterPro; IPR011013; Gal_mutarotase_sf_dom.
DR   InterPro; IPR000322; Glyco_hydro_31.
DR   InterPro; IPR030458; Glyco_hydro_31_AS.
DR   InterPro; IPR025887; Glyco_hydro_31_N_dom.
DR   InterPro; IPR013780; Glyco_hydro_b.
DR   InterPro; IPR017853; Glycoside_hydrolase_SF.
DR   InterPro; IPR000519; P_trefoil_dom.
DR   InterPro; IPR044913; P_trefoil_dom_sf.
DR   Pfam; PF13802; Gal_mutarotas_2; 2.
DR   Pfam; PF01055; Glyco_hydro_31; 2.
DR   Pfam; PF16863; NtCtMGAM_N; 2.
DR   Pfam; PF00088; Trefoil; 2.
DR   SMART; SM00018; PD; 2.
DR   SUPFAM; SSF51445; SSF51445; 2.
DR   SUPFAM; SSF57492; SSF57492; 2.
DR   SUPFAM; SSF74650; SSF74650; 2.
DR   PROSITE; PS00129; GLYCOSYL_HYDROL_F31_1; 1.
DR   PROSITE; PS00092; N6_MTASE; 1.
DR   PROSITE; PS51448; P_TREFOIL_2; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Disulfide bond; Glycoprotein; Glycosidase; Hydrolase;
KW   Membrane; Reference proteome; Repeat; Signal-anchor; Sulfation;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..2515
FT                   /note="Probable maltase-glucoamylase 2"
FT                   /id="PRO_0000341380"
FT   TOPO_DOM        1..9
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        10..30
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        31..482
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          41..88
FT                   /note="P-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00779"
FT   DOMAIN          904..950
FT                   /note="P-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00779"
FT   REGION          152..865
FT                   /note="Maltase"
FT                   /evidence="ECO:0000250"
FT   REGION          1023..1766
FT                   /note="Glucoamylase"
FT                   /evidence="ECO:0000250"
FT   REGION          1816..1901
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1994..2015
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2037..2091
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        478
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10066"
FT   ACT_SITE        481
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        1375
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10066"
FT   ACT_SITE        1378
FT                   /evidence="ECO:0000250"
FT   MOD_RES         371
FT                   /note="Sulfotyrosine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         1238
FT                   /note="Sulfotyrosine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        167
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        421
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        613
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2249
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        43..72
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00779"
FT   DISULFID        54..71
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00779"
FT   DISULFID        65..84
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00779"
FT   DISULFID        608..619
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00779"
FT   DISULFID        916..933
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00779"
FT   DISULFID        928..946
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00779"
FT   VAR_SEQ         478..482
FT                   /note="EMNEV -> VSYYS (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_055415"
FT   VAR_SEQ         483..2515
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_055416"
FT   CONFLICT        327
FT                   /note="F -> L (in Ref. 4; BC111973/BC111975)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   2515 AA;  277990 MW;  F6E8F08987335A4F CRC64;
     MARKLSVLEV LLIIFCLIVV TIDILLLLLV LEETSDTSFT PECPEIPQSE RIDCTPDQEV
     TEDICRWQYK CCWSPVADAN VPRCFFPWNW GYEASNGHTN TSTGFTAQLK RLPSPSLFGN
     DVATTLFTAE YQTSNRFHFK ITDFNNIRYE VSHENINLVD GIADASNLSY YVEVTDKPFS
     IKIMRTSNRR VLLDTSIGPL QFAQQYLQLS FRLPSANVYG LGEHVHQQYR HNMTWKTWPI
     FTRDATPTEG MINLYGAHTF FLCLEDARGS SFGVFLMNSN AMEVTLQPAP AITYRTIGGI
     LDFYVFLGNT PEQVVQEYLE LVGRPFFPPY WSLGFQLSRR DYGGINKLKE VVSRNRLAEI
     PYDVQYSDID YMDGKKDFTV DEVAYSGLPD FVKELHDNGQ KYLIIMNPGI SKNSNYEPYN
     NGSLKRVWIL GSNGFAVGEG YPGPTVFPDY TNPVCTEWWT DQVAKFHDHL EFDGVWIEMN
     EVSSLLQASN NQCESNNLNF PPFLPRVLDH LLFARTLCMD TEFHGGLHYD IHSLYGHSMA
     RTTNLALETI FMNNRSFILS RSTFAGSGKF AAHWLGDNAA TWDDLRWSIP TILEFNLFGI
     PMVGANICGY NNNVTEELCR RWMQLGAFYP LPRNHNGPGF RDQDPAAFGV DSLLLKSSRH
     YLNIRYTLLP YLYTLFYHAH TRGETVARPL VHEFYQDSAT WDVHEQFLWG PGLLITPVLY
     EGVDEVKAYI PDATWYDYET GVAISWRKQL VNMLLPGDKI GLHLRGGYIF PTQKPNTTTE
     ASRRNSLGLI IALDYKREAK GELYWDDGVS KDAVTEKKYI LYDFSVTSNH LQAKIINNNY
     MDTDNLMFTD ITILGMDKQP ANFIVLLNNV ATSSPSVVYN ASTKVVTITD LQGLVLGQEF
     SIRWNLPVSD LEKFNCYPDD PTASEESCRQ RGCLWEDTST PGVPTCYYDT IPNYVASDIQ
     YLNTSITADL SLPMAPESAA AAASDSLSAK ISFLHLKVIY HTATMLQVKI YDPTNKRYEV
     PVPLNTPPQP VGDPENRLYD VRIQNNPFGI QIQRKNSSTV IWDSQLPGFI FNDMFLSIST
     RLPSQYIYGF GETEHTTFRR NMNWNTWGMF AHDEPPAYKK NSYGVHPYYM ALEEDGSAHG
     VLLLNSNAMD VTLQPTPALT YRTTGGILDF YIVLGPTPEL VTQQYTELIG RPAMIPYWAL
     GFHLSRYGYQ NDAEISSLYD AMVAAQIPYD VQHVDIDYMN RKLDFTLSAN FQNLSLLIEQ
     MKKNGMRFIL ILDPAISGNE TQYLPFIRGQ ENNVFIKWPD TNDIVWGKVW PDLPNVIVDG
     SLDHETQVKL YRAYVAFPDF FRNSTAAWWK KEIEELYANP REPEKSLKFD GLWIDMNEPS
     NFVDGSVRGC SNEMLNNPPY MPYLESRDKG LSSKTLCMES QQILPDSSPV EHYNVHNLYG
     WSQTRPTYEA VQEVTGQRGV IITRSTFPSS GRWGGHRLGN NTAAWDQLGK SIIGMMEFSL
     FGIPYTGADI CGFFGDAEYE MCVRWMQLGA FYPFSRNHNN IGTRRQDPVA WNSTFEMLSR
     KVLETRYTLL PYLYTLMHKA HVEGSTVVRP LLHEFTDDRT TWDIDRQFML GPAILISPVL
     ETSTFEISAY FPRARWYDYS TGTSSTSTGQ RKILKAPLDH INLHVRGGYI LPWQEPAMNT
     HSSRQNFMGL IVALDDNGTA EGQVFWDDGQ SIDTYENGNY FLANFIAAQN ILQIQTIHNK
     YLSDSNPLKV GYIRIWGVNT YVTQVSFTYD NRQFMETNFK SEPYNQILTI QLTDKTINLE
     KLTEVTWIDG GPVLPTPTKT STIPMSSHPS PSTTNATSSE TITSSASANT TTGTTDTVPI
     TTTSFPSTTS VTTNTTVPDT TSPFPTSTTN ASTNATVPIT TTPFPTSTIG VTTNATVPNT
     TAPFPTNAST ASTNATVPIT TTCFATSTIG VTTNATVPDT TAPFPTNTTT ASTNATIPIT
     TTPFATSTIS VTTSTTVPDT TAPFPTSTTS ASTNATPVPI TTTLFATSTI GVTTGTTVPD
     TTAPFPTSTT STSTSATVPI TTTPSPTNTA DANTSNTVPN TTMPSPTSST TVSTIATVPI
     SVTPSLTSTA DATISTTVLI ATTSSLTGTT DVSTSTTINN ISTPVQTNTT NASTSTNVAN
     ITATSHTSTD DTVPNNTVPV TAIPSLANTG VDTTSNSFSI MTTSFSESTN AMNTTVIMAT
     TSPTSTDVAS TNNDASMTNF LLATMSAGNI TSNSISITTT SFGNSVPFVT TPSPSTDATT
     TSNNTNPGMT TYYQTSPTIP THTLTSIPSS ITSILSMFPT SNTFTTDKIT NFTTPTNANT
     IIFNTLDTKS TMVIDATVTT TSTKDNTMSP DTTVTSIDKF TTHITQFATP HSATTTTLAL
     SHTSLAPTNL SNLGTMDITD ADNSSSVTGN TTHISVSNLT TASVTITATG LDSQTPHMVI
     NSVATYLPIT ATSATTDTTN ITKYALNTTT PDSTVHTSAT APTYIANAIN ATQVP
//
